These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24969386)

  • 1. Medication pitfalls in the CKD clinic: case presentations.
    Liles AM
    Adv Chronic Kidney Dis; 2014 Jul; 21(4):349-54. PubMed ID: 24969386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication dosing in patients with chronic kidney disease.
    Zuber K; Liles AM; Davis J
    JAAPA; 2013 Oct; 26(10):19-25. PubMed ID: 24201917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chronic kidney disease patient in the acute hospital environment.
    Troidle L
    Adv Chronic Kidney Dis; 2014 Jul; 21(4):355-9. PubMed ID: 24969387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient safety issues in CKD: core curriculum 2015.
    Wagner LA; Tata AL; Fink JC
    Am J Kidney Dis; 2015 Jul; 66(1):159-69. PubMed ID: 25987263
    [No Abstract]   [Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitors in chronic kidney disease.
    Olyaei A; Steffl JL; MacLaughlan J; Trabolsi M; Quadri SP; Abbasi I; Lerma E
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):385-98. PubMed ID: 23975627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced rhabdomyolysis].
    Ueda S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():567-71. PubMed ID: 18072348
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication Safety Principles and Practice in CKD.
    Whittaker CF; Miklich MA; Patel RS; Fink JC
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1738-1746. PubMed ID: 29915131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD.
    Surana S; Kumar N; Vasudeva A; Shaikh G; Jhaveri KD; Shah H; Malieckal D; Fogel J; Sidhu G; Rubinstein S
    BMC Nephrol; 2017 Jan; 18(1):26. PubMed ID: 28095816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTC statins: a bad decision for public health.
    Lancet; 2004 May; 363(9422):1659. PubMed ID: 15158622
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis.
    Farag A; Garg AX; Li L; Jain AK
    Am J Kidney Dis; 2014 Mar; 63(3):422-8. PubMed ID: 24189475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OTC medication-induced nephrotoxicity in the elderly and CKD patient.
    Bednar B
    Nephrol News Issues; 2009 Jul; 23(8):36, 38-40, 43-4. PubMed ID: 19662909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of drugs in renal failure.
    Reed WE; Sabatini S
    Semin Nephrol; 1986 Sep; 6(3):259-95. PubMed ID: 3299583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National collaborative: Top five drugs reported as causing harm through medication error in pediatrics.
    Colquhoun M; Orrbine E; Sheppard I; Stromquist L; Koczmara C; Cheng R; Greenall J; Salsman B; Sabovitch S
    Dynamics; 2009; 20(4):20-2. PubMed ID: 20088358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of hepatotoxicity].
    Bertolami MC
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():25-7. PubMed ID: 16400394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and Knowledge Among Internal Medicine Resident Trainees for Dose Adjustment of Analgesics and Neuropsychotropic Medications in CKD.
    Saad CY; Fogel J; Rubinstein S
    South Med J; 2018 Mar; 111(3):155-162. PubMed ID: 29505650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
    Ponte B; Bourquin V; Stoermann-Chopard C
    Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication considerations for patients with chronic kidney disease who are not yet on dialysis.
    Liles AM
    Nephrol Nurs J; 2011; 38(3):263-70. PubMed ID: 21877459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An over-the-counter omission.
    Scheurer DB
    South Med J; 2006 Sep; 99(9):1005-6. PubMed ID: 17004539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adverse effects of lipid-lowering medications].
    Fukumoto Y; Shimokawa H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():165-72. PubMed ID: 18074533
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.